Sign in
4

Changes in Ownership

Cytosorbents Corp Filed Acc 0001104659-24-107142

Options or other derivatives

  • Chief Medical Officer acquired 150,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Deliargyris Efthymios Chief Medical Officer 2024-10-04 Grant or award · Stock Option (Right to Buy) +100,000 100,000 D
Deliargyris Efthymios Chief Medical Officer 2024-10-04 Grant or award · Stock Option (Right to Buy) +50,000 50,000 D
Loading xslF345X05/tm2425809-2_4seq1.xml…